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THE SELF-EFFICACY OF BIOLOGICAL MOTHERS AND FOSTER MOTHERS 
CARING FOR INFANTS PRENATALLY EXPOSED TO DRUGS OR TREATED FOR 
NAS: EXAMINATION OF POTENTIALLY INFLUENCING FACTORS 
Megan K. Sherehiy 
April 22, 2019 
This study sought to identify demographic risk and protective factors that may 
relate to parental self-efficacy in biological and foster mothers caring for infants 
prenatally exposed to opioids. The study also examined whether participation in 
treatment for biological mothers and in training for foster mothers was associated with 
parental self-efficacy. Forty-nine women (21 biological mothers and 28 foster mothers) 
were surveyed. Measures included demographic, treatment, and training information. A 
single-item, self-report measure was used to assess satisfaction with support from friends 
using an item from the World Health Organization Quality of Life-Bref scale 
(Skevington, Lotfy, & O'Connell, 2004). The Karitane Parenting Confidence Scale was 
used to measure mothers’ parental self-efficacy (Črnčec, Barnett, & Matthey, 2008). 
Results found significant differences in demographic representation between biological 
and foster mothers, but did not find a significant association between parental self-




TABLE OF CONTENTS 
 PAGE 
ACKNOWLEDGMENTS ................................................................................................ IV 
ABSTRACT ........................................................................................................................ V 
LIST OF TABLES .......................................................................................................... VIII 
INTRODUCTION ...............................................................................................................1 
Background ..............................................................................................................1 
Neonatal Abstinence Syndrome (NAS) .............................................................. 1 
Treatment for Mothers with Substance Use Disorders ....................................... 3 
Training for Foster Families Caring for Infants Exposed to Opioids ................. 5 
Problem Statement ...................................................................................................7 
Developmental Outcomes Related to NAS ........................................................ 7 
Early Experience & Environmental Impact on Development ............................ 8 
Maternal Self-Efficacy ...................................................................................... 11 
Specific Aims .........................................................................................................13 
Research Hypotheses .............................................................................................13 
Null Hypotheses ................................................................................................ 14 
METHODS ........................................................................................................................15 
Participants .............................................................................................................15 
Data Collection ......................................................................................................15 
Data Analysis .........................................................................................................17 
RESULTS ..........................................................................................................................19 
Descriptive and Summary Statistics ......................................................................19 







Future Directions ...................................................................................................39 
REFERENCES ..................................................................................................................41 
APPENDIX: ABBREVIATIONS .....................................................................................50 




LIST OF TABLES  
TABLE PAGE 
1. Demographic Characteristics of Participants. ............................................................... 23 
2. Number of Deliveries and Biological Children (Biological Mothers). ......................... 24 
3. Number of Biological and Foster Children (Foster Mothers). ...................................... 24 
4. Treatment Program Participation (Biological Mothers). .............................................. 24 
5. Type of Treatment Program in Current vs. Past Pregnancy (Biological Mothers). ...... 25 
6. Participation in Any Treatment Program (Biological Mothers). .................................. 26 
7. Amount of Specialized Foster Parent Training (Foster Mothers). ................................ 27 
8. Satisfaction with Support Received from Friends. ....................................................... 27 
9. Total Karitane Parenting Confidence Scale (KPCS) Scores......................................... 27 
10. Responses to Items on the Karitane Parenting Confidence Scale (KPCS). ................ 28 
11. Demographics: Biological Mothers vs. Foster Mothers (Ranks)................................ 30 
12. Demographics: Biological Mothers vs. Foster Mothers (Statistics). .......................... 31 
13. KPCS Scores for Biological Mothers in Past vs. Current Treatment (Ranks)............ 31 
14. KPCS Scores for Biological Mothers in Past vs. Current Treatment (Statistics). ...... 31 
15. KPCS Scores for Foster Mothers With vs. Without Training (Ranks). ...................... 32 






Neonatal Abstinence Syndrome (NAS) 
Neonatal abstinence syndrome (NAS) is a clinical diagnosis resulting from the 
discontinuation of fetal exposure to opioids (Hudak et al., 2012; Kocherlakota, 2014). 
NAS was first described in the 1970s, and more recently the designation of neonatal 
opioid withdrawal syndrome (NOWS) has been made to denote a specific classification 
of NAS estimated to affect 50 to 80% of infants exposed to opioids in utero (Kakko, 
Heilig, & Sarman, 2008; Reddy Uma, Davis, Ren, & Greene, 2017; Sutter, Leeman, & 
Hsi, 2014). 
While NAS is a general term used widely in existing literature, NOWS is being 
used to more accurately identify infants experiencing withdrawal from prenatal exposure 
to opioids; this distinction is clinically relevant because the assessment and treatment of 
these infants may differ compared to infants exposed to other substances (Klaman et al., 
2017). Since NAS occurs in 55 to 94% of newborns whose mothers used or were treated 
with opioids while pregnant, not all infants prenatally exposed to opioids will be 
diagnosed (McQueen & Murphy-Oikonen, 2016). Regardless, the current study sought to 
examine the impact of treatment programs for women who used opioids while pregnant 
in optimizing parental self-efficacy (PSE) and child outcomes in these high-risk 
populations, so it was inclusive of women who used a variety of drugs while pregnant in 
 
2 
addition to foster mothers caring for infants who were diagnosed with NOWS, NAS, or 
exposed but not diagnosed. The general term, NAS, is used here to reflect this broad 
inclusivity. 
Clinical signs of NAS usually present within the first few days of birth and vary 
in onset, type, and severity (McQueen & Murphy-Oikonen, 2016). Common signs 
include irritability, tremors, excessive crying, and diarrhea, with seizures sometimes 
occurring in more severe cases (Kocherlakota, 2014). As a result, newborns with NAS 
tend to be more agitated, have trouble sleeping, and experience difficulties feeding 
(Maguire, Rowe, Spring, & Elliott, 2015). The mild to severe illness associated with NAS 
often leads to prolonged hospital stays for the newborn (Kocherlakota, 2014). 
According to the Centers for Disease Control and Prevention, the overall 
incidence of NAS increased 300% from 1.5 per 1,000 hospital births in 1999 to six per 
1,000 hospital births in 2013 (Ko et al., 2016). In Kentucky, the rise was even more 
dramatic, climbing from .4 per 1,000 hospital births in 2000 to 15 per 1,000 hospital 
births in 2013 (Ko et al., 2016). This increase corresponds with the recent rise in opioid 
use during pregnancy, which has been linked to many contributing factors, including the 
higher use of prescribed opioids for pain control in pregnant women (McQueen & 
Murphy-Oikonen, 2016). 
Management of NAS involves nonpharmacological treatment methods such as 
gentle handling, on-demand feeding, swaddling, dim lighting, low noise, kangaroo care, 
and rooming-in of mother and infant (Kocherlakota, 2014). While preliminary studies 
have demonstrated benefits of these methods, additional large-scale, randomized 
controlled studies are needed to determine its effectiveness and establish standardized 
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guidelines (McQueen & Murphy-Oikonen, 2016). Since 60 to 80% of infants do not 
respond to nonpharmacological treatment, pharmacological treatment of symptoms with 
morphine, methadone, or buprenorphine is also an essential component in NAS 
management (Kocherlakota, 2014; McQueen & Murphy-Oikonen, 2016). Despite its 
widespread use, no universal standard of care exists for pharmacological treatment 
(McQueen & Murphy-Oikonen, 2016). Typically, clinicians use scoring systems, such as 
the Finnegan scoring system, to monitor and assess the severity of NAS, which can help 
determine when pharmacological treatment is needed and assist in monitoring, adjusting 
and ending therapy (Finnegan, Connaughton, Kron, & Emich, 1975; Kocherlakota, 
2014). 
Treatment for Mothers with Substance Use Disorders 
Efforts are being made, through formal programs and interventions, to assist 
women with modifying their behavior and thereby positively influencing the infant 
(Shaw et al., 2015). The mother’s participation in caring for her infant is potentially 
beneficial to both as she can learn about the neurobehavioral difficulties the infant may 
have and the special attention that will be required (Boukydis & Lester, 2008). This 
awareness and ability to actively participate in the infant’s care can enhance mother and 
infant interaction and bonding (Boukydis & Lester, 2008). 
There is no standardized treatment program for pregnant women with substance 
use disorders (SUD), but the World Health Organization (WHO) recommends that care 
adheres to the following principles: prioritizing prevention, ensuring access to prevention 
and treatment, respecting patient autonomy, providing comprehensive care, and 
safeguarding against discrimination and stigmatization (World Health Organization 
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guidelines for the identification and management of substance use and substance use 
disorders in pregnancy, 2014). 
Pharmaceutical management for pregnant women with SUD includes medication 
assisted withdrawal (MAW) or medication assisted treatment (MAT) (Klaman et al., 
2017). MAW has been found to pose a risk of relapse before delivery and is associated 
with poor prenatal outcomes (Kahn et al., 2017; Klaman et al., 2017). The American 
College of Obstetricians and Gynecologists recommends MAT with methadone or 
buprenorphine during pregnancy for women using opioids ("ACOG statement on opioid 
use during pregnancy," 2016). While methadone is more common, recent studies have 
found that buprenorphine might reduce the amount of morphine needed to treat newborns 
with NAS, reduce their length of hospital stay, lower risk of preterm birth, and contribute 
to greater birth weight and larger head circumference when compared with methadone 
treatment (Fischer et al., 2000; H. E. Jones et al., 2011; Kahn et al., 2017; Klaman et al., 
2017). 
Practitioners are also testing comprehensive treatment programs in outpatient and 
residential settings for pregnant women with SUD (Haug, Duffy, & McCaul, 2014). 
These programs may include MAT as well as prenatal and psychosocial care combined 
with education on pregnancy, delivery, postpartum care, and parenting (Buckley, 
Razaghi, & Haber, 2013; Haug et al., 2014; Kahn et al., 2017). Two models include 
relationship-focused intervention (RFI) and standard integrated treatment (SIT), both of 
which combine parenting support with addiction services for mothers who are pregnant 
or parenting young children (Espinet, Motz, Jeong, Pepler, & Jenkins, 2016). In a 
comparison of these models, Espinet et al. (2016) found that a higher number of women 
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who participated in RFI achieved addiction self-efficacy and that mothers with mental 
health issues saw reduced symptoms of depression and anxiety. In a review of programs 
that included relational aspects, Kramlich and Kronk (2015) found that early qualitative 
data indicates positive outcomes, such as mothers developing relationships with members 
of multidisciplinary teams essential for their healing and engagement in care. 
Despite the demonstrated benefit of these programs, many women with SUD 
encounter barriers to accessing resources, treatment programs, prenatal care, and 
parenting support (Fraser, Barnes, Biggs, & Kain, 2007; Kramlich & Kronk, 2015). 
These barriers can be particularly acute for pregnant women in rural areas, such as 
Appalachian Kentucky, where Brown, Goodin, and Talbert (2018) found higher relative 
rates of NAS along with a relative lack of access to treatment. Other barriers that this 
population might encounter include the stigmatization, and in some cases criminalization, 
of substance use, which can make women reluctant to seek treatment and prenatal care 
(Kramlich & Kronk, 2015; Lester, Andreozzi, & Appiah, 2004). 
Training for Foster Families Caring for Infants Exposed to Opioids 
With evidence showing that infants prenatally exposed to substances are more 
likely to be placed in foster care within months from birth, awareness of the need to 
support foster families who care for these infants and children is also growing (Eiden, 
Foote, & Schuetze, 2007). Children in foster care are at increased risk for behavioral and 
emotional problems, requiring additional training on parenting skills that may help 
manage or reduce adverse outcomes (Solomon, Niec, & Schoonover, 2017). 
Despite the clear need, there is a shortage of standardized programs and limited 
evidence on how to develop evidence-based programs that educate and support foster 
parents caring for infants prenatally exposed to substances (D'Angiulli & Sullivan, 2010; 
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Marcellus, Shaw, MacKinnon, & Gordon, 2017). However, programs are being 
developed, such as in Kentucky, where the Department of Community Based Services 
(DCBS) offers training in the topic area of “the effect of substance use, abuse, or 
dependency by either the child or the child’s biological parent” as an additional training 
not required for Basic level foster home approval (Cabinet for Health and Family 
Services Online Standards of Practice Manual, 2018). 
Both kinship and non-relative foster parents offer a familial environment that 
contributes to ensuring the safety, stability, and well-being of children and youth (Lietz, 
Julien-Chinn, Geiger, & Piel, 2016). Though fathers may also provide foster care, the 
mother typically takes more responsibility for daily child care and communication with 
the birth family (Wilson, Fyson, & Newstone, 2007). Day-to-day caretaking of an infant 
who may have been affected by intrauterine exposure or treated for NAS can include loss 
of sleep, coordination of the baby’s health care and therapies as needed, provision of 
adequate nutrition, and service as an interpreter for the infant’s behavioral cues 
(Marcellus et al., 2017). 
Current research indicates that early foster care may provide a supportive 
environment for positive developmental outcomes as it can potentially counteract early 
deficits associated with prenatal exposure (D'Angiulli & Sullivan, 2010). When 
supported with training and resources that promote resiliency, which can influence self-
efficacy, foster families can provide a protective caregiving environment in which infants 




Developmental Outcomes Related to NAS 
In addition to its immediate clinical signs, NAS is also associated with early 
cognitive and motor delays, as prenatal exposure to drugs can impact fetal development 
of brain structures and function (Ko et al., 2016; Logan, Brown, & Hayes, 2013; Ross, 
Graham, Money, & Stanwood, 2015). There are a variety of mechanisms related to 
intrauterine exposure that can potentially have consequences long after birth, including 
drugs that cross the placenta acting on the fetus directly, affecting the placenta or uterus, 
and indirectly resulting in harm due to destructive maternal behavior related to addiction 
(Ross et al., 2015). Though all prenatal drug use can negatively impact a fetus, factors 
such as the type of drug or drugs used, the amount, and the most recent use can influence 
symptoms presented after birth (Ross et al., 2015). 
Studies focusing on infancy and early childhood have found that infants born to 
mothers who used opioids or polysubstances during pregnancy had lower cognitive 
performance and affect regulation, as well as smaller neuroanatomical volumes and lesser 
maturation of neural tracts than non-exposed infants (Nygaard, Moe, Slinning, & 
Walhovd, 2015). Children with a diagnosis of NAS have also been found to be at 
increased risk of being rehospitalized due to visual disorders, mental health issues, and 
behavioral problems (Uebel et al., 2015). However, according to Nygaard et al. (2015) 
few studies to date have followed children exposed to opioids in utero past their first 
years of life to determine specific long-term implications. 
Complicating matters, the confounding issues of polysubstance use and co-
occurring environmental and medical risk factors may interact with prenatal exposure, 
leading to epigenetic changes that can have immediate and long-term implications on 
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development (Lester et al., 2011). For example, children prenatally exposed to opioids 
may exhibit decreased long-term cognitive functioning, but exposure to polysubstances 
makes isolating causality challenging (Nygaard et al., 2015). Environmental risk factors 
include low socioeconomic status, nonoptimal postnatal environment, and lower maternal 
education and employment, while medical risk factors include poor prenatal care, low 
birth weight, and severity and treatment for NAS (Konijnenberg & Melinder, 2015; 
Logan et al., 2013; Nygaard et al., 2015). In addition, children of mothers using illicit 
substances are at a higher risk for poor outcomes due to on average lower levels of 
maternal sensitivity among populations at heightened risk for poor child outcomes due to 
the environmental risk factors previously mentioned and residing in areas associated with 
financial disadvantage (Hatzis, Dawe, Harnett, & Barlow, 2017). 
Early Experience & Environmental Impact on Development 
While long-term developmental outcomes for infants exposed to opioids in utero 
are unclear, there is evidence supporting the influence of early experiences and 
environment on the developing brain, and in turn on the progression of overall 
development (Fox, Levitt, & Nelson, 2010; Inguaggiato, Sgandurra, & Cioni, 2017; 
Tierney & Nelson, 2009). Specifically, parent-child interaction, nutrition, and 
neuroendocrine signals have been identified as significant experiential and environmental 
factors that influence the maturation of neural circuits and play a role in physical and 
mental changes (Inguaggiato et al., 2017). These changes reflect the neuroplasticity that 
exists as a result of complex processes and interactions that occur throughout life 
(Knudsen, 2004). Though changes take place across the life span, there are vital 
windows, or sensitive periods, in which experiences either potentiate or inhibit neural 
connections; and when neural connections necessary for normal development are 
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established and result in permanent changes, sensitive periods are termed critical periods 
(Knudsen, 2004).  
Early experience and environment influence speech, language, and cognitive 
development (Tierney & Nelson, 2009). Play emerges through experience, allowing a 
child to interact with his or her environment in ways that encourage the emergence of 
advanced skills and competencies (Blasi & Hurwitz, 2002). Feeding and nutritional 
intake are also influenced, both physiologically and relationally, by early experiences 
(Harbron & Booley, 2013; Shloim, Edelson, Martin, & Hetherington, 2015; Worobey, 
Lopez, & Hoffman, 2009).  
While healthy experiences support neural development, the lack of positive 
experiences or experiencing toxic stress prenatally or in early childhood during sensitive 
periods can be detrimental (Shonkoff & Garner, 2012). Adverse childhood experiences 
(ACEs) can produce this toxic stress response, which has the potential to lead to impaired 
language, attention, and social-emotional skills, such as social communication and 
impulse control (Anda et al., 2006; Henry, Sloane, & Black-Pond, 2007; Shonkoff & 
Garner, 2012). However, neuroplasticity allows for improvement of cognitive function 
and self-regulation impaired by early life experiences (McEwen & Morrison, 2013). 
As a means of discovering the influence of early experiences on development, 
researchers from three major institutions created the Bucharest Early Intervention Project 
(BEIP) to examine the effects of institutionalization on infants and young children 
(Marshall, Fox, & The Bucharest Early Intervention Project Core, 2004). Although 
institutions vary, many are characterized by unfavorable caregiver-to-child ratios with 
low levels or responsivity, strict routines, and minimal stimulation, which was true of the 
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institutions included in this project due to the extraordinary number of orphaned and 
abandoned children in Romania at the time (Marshall et al., 2004). 
As part of the initiative, Marshall et al. (2004) examined electroencephalography 
(EEG) data from a sample of infants and young children who were institutionalized and 
compared it to data of age-matched peers from the local area who had never been 
institutionalized and who lived with their families. The institutionalized sample showed 
EEG results that were consistent with EEG studies of children who were living in adverse 
environments and children with diagnosed learning disorders, reflecting a lag in central 
nervous system development (Marshall et al., 2004). A follow-up study of the children in 
the 2004 sample compared the children who were institutionalized to the children who 
had been randomly assigned to foster care and found that the EEGs of children who were 
transferred to foster care reflected positive neurophysiological changes in the central 
nervous system, with these changes partly dependent on age at placement into foster care 
(Marshall, Reeb, Fox, Nelson, & Zeanah, 2008). 
In another study from the BEIP, Nelson et al. (2007) compared the development 
of young children who were abandoned and placed in institutions to the development of 
young children who were placed in institutions but later transferred to foster care, and to 
age-matched peers who had never been institutionalized and who lived with their 
families. All children were less than 31 months at the initiation of the study and were 
assessed at intervals through the age of 54 months using the Bayley Scales of Infant 
Development-II (BSID-II) (Bayley, 1993) and the Wechsler Preschool Primary Test of 
Intelligence (WPPSI) (Wechsler, 1967) (Nelson et al., 2007). Children who remained 
institutionalized had severely diminished intelligence scores compared to the children 
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who had never been institutionalized, while the children who were initially 
institutionalized but moved to foster care exhibited improvements in cognitive scores 
with greater gains positively correlated to earlier placement in foster homes (Nelson et 
al., 2007). 
Maternal Self-Efficacy 
Recognition of the role of early experiences and environment, which are inclusive 
of caregiver and child interaction (Inguaggiato et al., 2017), and of critical developmental 
stages (Knudsen, 2004), highlights the importance of prevention first, but also in 
optimizing the care of infants who were exposed to opioids in utero. The ability to 
participate in the infant’s care can enhance mother and infant interaction and bonding, 
which can influence early experiences and facilitate a supportive environment (Coleman 
& Karraker, 2003). 
Maternal self-efficacy (MSE) is an essential construct concerning a mother’s 
ability to provide appropriate care and a nurturing environment. MSE is a mother’s 
dynamic belief about her ability to perform the multiple tasks associated with caring for 
her child that can be influenced by both internal and external factors, and is considered to 
impact actual parenting behaviors (Salo et al., 2009; Troutman, Moran, Arndt, Johnson, 
& Chmielewski, 2012). 
The belief in one’s parenting ability is critical as higher self-efficacy is associated 
with mothers being more attentive, sensitive, and interactive, and with infants possessing 
a greater capacity to signal, to interact positively, and to develop cognitively (Coleman & 
Karraker, 2003). Higher PSE is related to parenting behaviors conducive to a positive 
child-rearing environment, which maximizes children’s development and leads to 
improved long-term outcomes, including higher self-regulation and self-worth, lower 
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levels of anxiety, improved academic performance, and fewer behavioral problems in 
adolescents (Bogenschneider, Small, & Tsay, 1997; Coleman & Karraker, 2003; Hill & 
Bush, 2001; Murry & Brody, 1999). In contrast, low PSE might be considered a 
predictive risk factor of child maltreatment, as lacking the confidence in oneself to parent 
successfully may lead to harsher parenting practices that have the potential to develop 
into abuse (T. L. Jones & Prinz, 2005).  
Self-efficacy can be susceptible to a variety of factors. According to the theory 
posited by Bandura (1982), there are four ways to modify self-efficacy: 1) Enactive 
mastery, such as gaining personal experience in certain activities, 2) Vicarious 
experiences, such as observing competent models of challenging activities, 3) Verbal and 
social persuasion, such as receiving verbal feedback related to performance of a specific 
task, and 4) Emotional and physiological arousal, such as the experience of emotions 
and/or physiological responses such as stress related to specific tasks.  
Higher levels of education and household income have also been found to predict 
higher overall PSE (Coleman & Karraker, 2003; Shorey, Chan, Chong, & He, 2015). 
Coleman and Karraker (2003) attribute this to a broader knowledge of child development 
and effective parenting strategies, as well as the ability to provide more goods, 
experiences, and opportunities for their children while investing in social supports such 
as babysitters to reduce stress on mothers. Other variables that may affect PSE have been 
examined, such as increased demands associated with caring for medically complex 
infants and children (Meirsschaut, Roeyers, & Warreyn, 2010; Porter & Hsu, 2003) and 
satisfaction with marital and social support (Kersh, Hedvat, Hauser-Cram, & Warfield, 
2006; Teti & Gelfand, 1991). 
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This study seeks to determine those factors that best encourage favorable PSE so 
that efforts can be made to ensure the necessary supports are available for families caring 
for infants who were prenatally exposed to opioids. 
Specific Aims 
The specific aims of this study were to examine the following: 1. The 
identification of potential demographic risk and protective factors that may relate to PSE 
in mothers who used opioids during pregnancy; 2. The identification of potential 
demographic risk and protective factors that may relate to PSE in foster mothers caring 
for infants who were prenatally exposed to opioids; 3. The PSE of mothers who have 
used opioids during past or current pregnancies and who have delivered infants whose 
intrauterine development may have been impacted by prenatal exposure to opioids; and, 
4. The PSE of foster mothers who care for infants whose intrauterine development may 
have been affected by prenatal exposure to opioids. 
Research Hypotheses 
The research hypotheses are as follows. Note that formal treatment programs for 
biological mothers include any single or combination of the following: pharmacological 
treatment, outpatient treatment that included pharmacological treatment as well as 
counseling and education on the effects of prenatal substance exposure, and residential 
treatment that included pharmacological treatment as well as counseling and education on 
the effects of prenatal substance exposure. 
H1: There will be a significant difference in the demographic representation, 
based on age, marital status, education, employment, and income, between biological 
mothers and foster mothers. 
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H2: Biological mothers who participated in formal programs to treat their 
addiction during their current pregnancy will have higher perceived parenting self-
efficacy than biological mothers who participated in formal programs during a past 
pregnancy. 
H3: Foster mothers who received at least five hours of specialized training 
relating to prenatal drug exposure or neonatal abstinence syndrome will have higher 
perceived parenting self-efficacy than those who have not received specialized training. 
Null Hypotheses 
H01: There will not be a significant difference in the demographic representation, 
based on age, marital status, education, employment, and income, between biological 
mothers and foster mothers. 
H02: Biological mothers who participated in formal programs to treat their 
addiction during their current pregnancy will not have higher perceived parenting self-
efficacy than biological mothers who participated in formal programs during a past 
pregnancy. 
H03: Foster mothers who received at least five hours of specialized training 
relating to prenatal drug exposure or neonatal abstinence syndrome will not have higher 






Approval for this study was granted by the Institutional Review Boards (IRB) of 
the University of Louisville (IRB # 18.0268) and Norton Healthcare Research Office 
(RO). This study utilized a patient survey administered in person to biological mothers 
and foster mothers at Norton Children’s Neonatology (NCN) clinic and the Center for 
Behavioral Health (CBH) in Louisville, Kentucky. A total of 49 mothers participated in 
the study, including 21 biological mothers and 28 foster mothers. Eligible participants 
included mothers who used or were treated with opioids during pregnancy and foster 
mothers who cared for infants who had been prenatally exposed to opioids. In addition, 
participants also met all of the following conditions: 1. The participant’s infant received 
follow up at NCN clinic or the participant was receiving treatment at the CBH; 2. The 
participant was between 18 years and 50 years of age; and, 3. The participant 
demonstrated sufficient understanding of informed consent and was able to read and 
understand questionnaire items. Patients were excluded if they met any of the following 
criteria: 1. Patients were below age 18 years of age; 2. Patients had a diagnosis of 
intellectual disability; and, 3. Patients did not care for an infant who was prenatally 
exposed. 
Data Collection 
Mothers were approached by student researchers to complete the survey at 
follow-up visits at NCN or treatment sessions at the CBH. Student researchers provided 
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patients with a formal handout that included a brief explanation of the study and contact 
information for the principal investigator (PI) as a resource for questions about the study. 
If the patient agreed to participate, a paper or electronic copy of the survey was provided 
by the student researcher. Electronic copies of the survey were set up in Qualtrics, an 
online survey platform, and completed by the participant on a tablet computer. The 
survey contained a preamble in which completion of the tool verified consent. Each 
participant was involved in the study for the duration of the survey. Student researchers 
collected surveys at NCN clinic for one to two days a week from May 18, 2018 to 
October 23, 2018, and at the CBH for one day on November 6, 2018. 
There were two versions of the survey; one version was for biological mothers 
and one version was for foster mothers. The survey for biological mothers included self-
report treatment participation questions in which mothers indicated programs accessed 
during the current pregnancy or past pregnancies. The survey for foster mothers included 
a self-report training question in which mothers stated the hours of foster parent training 
received in the last 12 months that was related to prenatal drug exposure. Both versions 
presented self-report demographic questions, including zip code of residence, age, 
number of children, number of deliveries, marital status, level of education, employment 
status, racial-ethnic background, and annual household income. Foster mothers were also 
asked to report number of foster children cared for in the past and number of foster 
children currently in their care. 
A single-item, self-report measure was developed to assess satisfaction with 
support received from friends using an item from the World Health Organization Quality 
of Life (WHOQOL) Bref scale (Skevington et al., 2004). Satisfaction with the support of 
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friends was measured by the question: “How satisfied are you with the support you get 
from your friends?” with the response scale ranging from 1 - “Very dissatisfied” to 9 - 
“Very satisfied.” The Karitane Parenting Confidence Scale (KPCS), a validated 15-item 
self-report instrument was used to measure mothers’ perceived parental self-efficacy 
(PPSE) related to caring for the infant. Items on the KPCS are rated on a 4-point Likert 
scale with higher scores representing increased PPSE. The KPCS provides clinical ranges 
of non-clinical, mild, moderate, or severe related to the total score, with scores at 39 and 
below indicative of low parenting confidence (Črnčec et al., 2008). The scale included a 
preamble; thus minimal instruction was required during administration. 
Data Analysis 
All completed surveys were exported from Qualtrics to Excel (Microsoft) and 
numerically coded in preparation for analysis. Data were exported to SPSS Version 25 
(Microsoft) for statistical analysis, checked for distribution, and normalization 
transformations were applied. Descriptive and summary statistics values were calculated 
to describe the sample. Wilcoxon Signed-Rank Tests were conducted to assess whether 
there was a significant difference in the demographic representation, based on age, 
marital status, education, employment, and income, between biological mothers and 
foster mothers. A Mann-Whitney U Test was conducted to assess whether an association 
existed between PPSE and participation in formal treatment programs during past 
pregnancies compared to participation in formal treatment programs during the current 
pregnancy for biological mothers. A Mann-Whitney U Test was also conducted to assess 
whether an association existed between PPSE and participation in specialized training 
relating to prenatal drug exposure for foster mothers. Descriptive and summary statistics, 
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as well as the results of these analyses, are provided in Chapter 3. Continuous data 





Descriptive and Summary Statistics 
This study utilized a patient survey administered in person to women (N = 49) at 
NCN clinic and the CBH. Participants included biological mothers (n = 21) and foster 
mothers (n = 28). The age of participants ranged from 18 to 50 years, with 48% (n = 23) 
of all participants within the age range of 26-33 years. Of all participants, 90% (n = 43) 
of participants identified as Caucasian, 8% (n = 4) identified as African American, and 
2% (n = 1) identified as Pacific Islander. 
Biological mothers reported number of deliveries ranging from one to five or 
more (2 ± 1) and number of biological children ranging from one to five or more (2 ± 1). 
Foster mothers reported number of biological children ranging from zero to four (2 ± 1), 
number of foster children cared for in the past ranging from zero to four (2 ± 2), and 
number of foster children currently in their care ranging from one to four (2 ± 1). 
During a past or current pregnancy, 86% (n = 18) of biological mothers reported 
participating in at least one formal treatment. During their current pregnancy, 14% (n = 3) 
participated in an outpatient program, 24% (n = 5) participated in a residential program, 
5% (n = 1) participated in pharmacological and residential programs, 5% (n = 1) 
participated in pharmacological, outpatient, and residential programs, and 10% (n = 2) 
did not participate in any program. Nine participants (43%) did not provide an answer 
regarding participation in treatment programs during current pregnancies. During a past 
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pregnancy, 38% (n = 8) participated in an outpatient program, 5% (n = 1) participated in 
pharmacological and residential programs, 10% (n = 2) participated in outpatient and 
residential programs, and 5% (n = 1) did not participate in any program. Nine mothers 
(43%) did not provide an answer regarding participation in treatment programs during 
past pregnancies. 
Nine foster mothers (39%) reported participating in at least five hours of 
specialized foster parent training relating to prenatal drug exposure within the past 12 
months. In the sample, 30% (n = 7) of mothers participated in five hours or less of 
specialized foster parent training, 9% (n = 2) of mothers participated in 13-24 hours of 
training, and 61% (n = 14) of mothers did not participate in training. Five mothers (18%) 
did not provide an answer regarding participation in specialized training. 
Regarding satisfaction with support received by friends, 14% (n = 3) of biological 
mothers were very dissatisfied, 5% (n = 1) were moderately dissatisfied, and 5% (n = 1) 
were slightly dissatisfied. No foster mothers indicated being very dissatisfied or 
moderately dissatisfied with support received from friends, and 12% (n = 3) were slightly 
dissatisfied. Nineteen percent (n = 4) of biological mothers were very satisfied with 
support received from friends, 14% (n = 3) were moderately satisfied, and 33% (n = 7) 
were slightly satisfied. Of the foster mothers reporting, 39% (n = 10) were very satisfied, 
15% (n = 4) were moderately satisfied, and 31% (n = 8) were slightly satisfied. 
Total KPCS scores for all mothers ranged from 35 to 45 (Mdn = 42), with total 
scores for biological mothers ranging from 35 to 45 (Mdn = 42) and total scores for foster 
mothers also ranging from 35 to 45 (Mdn = 42). Twenty percent (n = 4) of biological 
mothers scored in the clinical range, with 15% (n = 3) scoring in the mild clinical range 
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and 5% (n = 1) scoring in the moderate clinical range. Of the foster mothers, 18% (n = 5) 
scored in the clinical range, with 14% (n = 4) scoring in the mild clinical range and 4% (n 
= 1) scoring in the moderate clinical range. 
See Tables 1-10 for more detail regarding descriptive and summary statistics. 
Non-Parametric Analysis 
Wilcoxon Signed-Rank Tests were conducted to compare demographic variables 
between biological mothers and foster mothers. Tests indicated that the median test rank 
for the biological mothers was statistically significantly lower than the median test rank 
for the foster mothers in the areas of age (Z = -2.30, p = 0.02); marital status (Z = -3.32, p 
= 0.001); education level (Z = -2.11, p = 0.04); and, household income (Z = -3.29, p = 
0.001). Biological mothers ranged in age from 18-25 to 42-50 (Mdn = 26-33), and foster 
mothers ranged in age from 18-25 and 42-50 (Mdn = 34-41). The median marital status 
was “Never Married” for biological mothers and “Currently Married” for foster mothers. 
The median educational level was “High School” for biological mothers and “Technical 
School” or “Bachelor’s Degree” for foster mothers. Biological mothers reported 
household incomes ranging from $0-$20,000 to $100,000 and above (Mdn = $20,000-
$39,999). Foster mothers reported household incomes ranging from $0-$20,000 to 
$100,000 and above (Mdn = $60,000-$79,999). There was not a statistically significant 
difference in employment status between the two samples of mothers (Z = -1.61, p = 
0.11). See tables 11-12 for more detail. 
A Mann-Whitney U Test was conducted to compare total KPCS scores of 
biological mothers who participated in a formal treatment program during a past 
pregnancy (n = 11) to biological mothers who participated in a formal treatment program 
during their current pregnancy (n = 9). One biological mother’s score was not included in 
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the test due to no responses on three KPCS items. The analysis indicated that there was 
no statistically significant difference in total KPCS scores of biological mothers who had 
completed formal treatment programs during a past pregnancy (Mdn = 42) compared to 
biological mothers who had completed formal treatment programs during the current 
pregnancy (Mdn = 41; U = 37.00, p = 0.37). See tables 13-14 for more detail. 
A Mann-Whitney U Test was also conducted to compare total KPCS scores for 
foster mothers who had completed at least five hours of specialized foster parent training 
relating to prenatal drug exposure (n = 9) to foster mothers who had completed no 
specialized training (n = 14). The test indicated that there was no statistically significant 
difference in total KPCS scores of foster mothers who had received specialized training 
(Mdn = 41) and foster mothers who had not received specialized training (Mdn = 43; U = 













  n % n % N % 
Age 18-25 3 14% 1 4% 4 8% 
 26-33 13 62% 10 37% 23 48% 
 34-41 3 14% 4 15% 7 15% 
 42-50 2 10% 12 44% 14 29% 
        
Marital Status Never Married 12 57% 4 14% 16 33% 
 Married 3 14% 19 68% 22 45% 
 Partnered 3 14% 0 0% 3 6% 
 Separated 1 5% 1 4% 2 4% 
 Divorced 2 10% 3 11% 5 10% 
 Widowed 0 0% 1 4% 1 2% 
        
Education High School 13 62% 11 39% 24 49% 
 Technical School 4 19% 3 11% 7 14% 
 Bachelor's Degree 4 19% 10 36% 14 29% 
 Master's Degree 0 0% 4 14% 4 8% 
        
Employment Not working 10 48% 6 21% 16 33% 
 10-20 hours 1 5% 2 7% 3 6% 
 20-35 hours 4 19% 2 7% 6 12% 
 36+ hours 6 29% 18 64% 24 49% 
        
Race Caucasian 19 91% 24 89% 43 90% 
 African American 1 5% 3 11% 4 8% 
 Pacific Islander 1 5% 0 0% 1 2% 
        
Income $0-$20,000 11 52% 5 19% 16 34% 
 $20,000 - $39,999 7 33% 0 0% 7 15% 
 $40,000 - $59,999 1 5% 4 15% 5 11% 
 $60,000 - $79,999 0 0% 5 19% 5 11% 
 $80,000 - $99,999 1 5% 7 27% 8 17% 





Number of Deliveries and Biological Children (Biological Mothers). 
 Biological Mothers 
 M + SD Min Max 
Number of Deliveries 2 + 1 1 5+ 
Number of Biological Children 2 + 1 1 5+ 
 
Table 3 
Number of Biological and Foster Children (Foster Mothers). 
 Foster Mothers 
 M + SD Min Max 
Number of Biological Children 2 + 1 0 4 
Number of Foster Children (Past) 2 + 2 0 4 
Number of Foster Children (Current) 2 + 1 1 4 
 
Table 4 




 Biological Mothers 
 n % 
Any Program None 3 
18 
14% 





Type of Treatment Program in Current vs. Past Pregnancy (Biological Mothers). 
Pregnancy Type of Program* f % Valid % Cum. % 
Current 
Pregnancy Valid 9 43% 43% 43% 
 None 2 10% 10% 52% 
 Pharm, OP, Res 1 5% 5% 57% 
 Pharm, Res 1 5% 5% 62% 
 OP 3 14% 14% 76% 
 Res 5 24% 24% 100% 
 Total 21 100% 100%  
      
Past 
Pregnancy Valid 9 43% 43% 43% 
 None 1 5% 5% 48% 
 Pharm, Res 1 5% 5% 52% 
 OP 8 38% 38% 91% 
 OP, Res 2 10% 10% 100% 
  Total 21 100% 100%   





Participation in Any Treatment Program (Biological Mothers). 
Type of 
Program*  f % Valid % Cum. % 
Any 
Program Valid     
 Did Not Participate 5 24% 24% 24% 
 Participated 16 76% 76% 100% 
 Total 21 100% 100%  
      
Pharm Valid     
 Did Not Participate 18 86% 86% 86% 
 Participated 3 14% 14% 100% 
 Total 21 100% 100%  
      
OP Valid     
 Did Not Participate 8 38% 38% 38% 
 Participated 13 62% 62% 100% 
 Total 21 100% 100%  
      
Res Valid     
 Did Not Participate 11 52% 52% 52% 
 Participated 10 48% 48% 100% 
  Total 21 100% 100%   




Amount of Specialized Foster Parent Training (Foster Mothers). 
 Foster Mothers 
Amount of Specialized Training n % 
None 14 61% 
5 Hours or Less 7 30% 
13-24 Hours 2 9% 
 
Table 8 
Satisfaction with Support Received from Friends. 
 Biological Mothers Foster Mothers Total Sample 
Level of Satisfaction n % n % N % 
Very Dissatisfied 3 14% 0 0% 3 6% 
Moderately Dissatisfied 1 5% 0 0% 1 2% 
Slightly Dissatisfied 1 5% 3 12% 4 9% 
Neither 2 10% 1 4% 3 6% 
Slightly Satisfied 7 33% 8 31% 15 32% 
Moderately Satisfied 3 14% 4 15% 7 15% 
Very Satisfied 4 19% 10 39% 14 30% 
 
Table 9 
Total Karitane Parenting Confidence Scale (KPCS) Scores. 
 Biological Mothers Foster Mothers Total Sample 
 Mdn Min Max Mdn Min Max Mdn Min Max 













KPCS Item Response on KPCS n % n % N % 
Item 1 N/A 0 0% 0 0% 0 0% 
 No, hardly ever 1 5% 0 0% 1 2% 
 No, not very often 0 0% 0 0% 0 0% 
 Yes, some of the time 0 0% 0 0% 0 0% 
 Yes, most of the time 20 95% 28 100% 48 98%         
Item 2 No, hardly ever 0 0% 0 0% 0 0% 
 No, not very often 0 0% 0 0% 0 0% 
 Yes, some of the time 1 5% 3 11% 4 8% 
 Yes, most of the time 20 95% 25 89% 45 92%         
Item 3 No, hardly ever 0 0% 0 0% 0 0% 
 No, not very often 0 0% 0 0% 0 0% 
 Yes, some of the time 4 19% 2 7% 6 12% 
 Yes, most of the time 17 81% 26 93% 43 88%         
Item 4 No, hardly ever 0 0% 0 0% 0 0% 
 No, not very often 0 0% 0 0% 0 0% 
 Yes, some of the time 2 10% 2 7% 4 8% 
 Yes, most of the time 19 96% 26 93% 45 92%         
Item 5 No, hardly ever 0 0% 0 0% 0 0% 
 No, not very often 0 0% 0 0% 0 0% 
 Yes, some of the time 3 14% 7 25% 10 20% 
 Yes, most of the time 18 86% 21 75% 39 80%         
Item 6 No, hardly ever 0 0% 0 0% 0 0% 
 No, not very often 0 0% 0 0% 0 0% 
 Yes, some of the time 1 5% 5 18% 6 12% 
 Yes, most of the time 20 95% 23 82% 43 88%         
Item 7 No, hardly ever 0 0% 0 0% 0 0% 
 No, not very often 0 0% 0 0% 0 0% 
 Yes, some of the time 0 0% 2 7% 2 4%  
 Yes, most of the time 21 100% 26 93% 47 96% 




Item 8 No, hardly ever 0 0% 0 0% 0 0% 
 No, not very often 0 0% 0 0% 0 0% 
 Yes, some of the time 4 19% 7 25% 11 22% 
 Yes, most of the time 17 81% 21 75% 38 78% 
        
Item 9 N/A 3 14% 4 14% 7 14% 
 No, hardly ever 1 5% 0 0% 1 2% 
 No, not very often 2 10% 1 4% 3 6% 
 Yes, some of the time 3 14% 2 7% 5 10% 
 Yes, most of the time 12 57% 21 75% 33 67%         
Item 10 No, hardly ever 0 0% 0 0% 0 0% 
 No, not very often 0 0% 0 0% 0 0% 
 Yes, some of the time 1 5% 2 7% 3 6% 
 Yes, most of the time 20 95% 26 93% 46 94%         
Item 11 No, hardly ever 0 0% 0 0% 0 0% 
 No, not very often 0 0% 0 0% 0 0% 
 Yes, some of the time 0 0% 1 4% 1 2% 
 Yes, most of the time 21 100% 27 96% 48 98%         
Item 12 No, hardly ever 2 10% 7 25% 9 19% 
 No, not very often 4 20% 11 39% 15 31% 
 Yes, some of the time 13 65% 10 36% 23 48% 
 Yes, most of the time 1 5% 0 0% 1 2%         
Item 13 No, hardly ever 0 0% 0 0% 0 0% 
 No, not very often 0 0% 0 0% 0 0% 
 Yes, some of the time 6 30% 7 26% 13 27% 
 Yes, most of the time 14 70% 21 75% 35 73%         
Item 14 No, hardly ever 0 0% 0 0% 0 0% 
 No, not very often 0 0% 0 0% 0 0% 
 Yes, some of the time 3 15% 4 14% 7 15% 
 Yes, most of the time 17 85% 24 86% 41 85%         
Item 15 No, hardly ever 1 5% 0 0% 1 2% 
 No, not very often 0 0% 0 0% 0 0% 
 Yes, some of the time 6 29% 9 32% 15 31% 





Demographics: Biological Mothers vs. Foster Mothers (Ranks). 
 Ranks 
  n Mean Rank Sum of Ranks 
Age Negative Ranks 11a 8.05 88.50 
 Positive Ranks 3 5.50 16.50 
 Ties 4   
 Total 18   
Marital Status Negative Ranks 14d 8.36 117.00 
 Positive Ranks 1 3.00 3.00 
 Ties 3   
 Total 18   
Educational Level Negative Ranks 10g 9.65 96.50 
 Positive Ranks 5 4.70 23.50 
 Ties 3   
 Total 18   
Employment Status Negative Ranks 10j 8.75 87.50 
 Positive Ranks 5 6.50 32.50 
 Ties 3   
 Total 18   
Household Income Negative Ranks 15m 10.70 160.50 
 Positive Ranks 3 3.50 10.50 
 Ties 0   
  Total 18     
a. Age (biological mothers) < Age (foster mothers); d. Marital Status (biological mothers) < Marital Status 
(foster mothers); g. Educational Level (biological mothers) < Educational Level (foster mothers); j. 
Employment Status (biological mothers) < Employment Status (foster mothers); m. Household Income 





Demographics: Biological Mothers vs. Foster Mothers (Statistics). 
 Test Statisticsa 
 Z p 
Age -2.30b 0.02 
Marital Status -3.32b 0.001 
Educational Level -2.11b 0.04 
Employment Status -1.61b 0.11 
Household Income -3.29b 0.001 
a. Wilcoxon Signed Ranks Test 
b. Based on positive ranks. 
 
Table 13 
KPCS Scores for Biological Mothers in Past vs. Current Treatment (Ranks). 
  Ranks 
 Group n Mean Rank Sum of Ranks 
KPCS Score Current Pregnancy 9 9.11 82.00 
 Past Pregnancy 11 11.64 128.00 
  Total 20     
 
Table 14 
KPCS Scores for Biological Mothers in Past vs. Current Treatment (Statistics). 
Test Statisticsa 
 KPCS Score 
Mann-Whitney U 37.00 
Wilcoxon W 82.00 
Z -0.98 
Asymp. Sig. (2-tailed) 0.33 
Exact Sig. [2*(1-tailed Sig.)] 0.37b 
a. Grouping Variable: group 





KPCS Scores for Foster Mothers With vs. Without Training (Ranks). 
 Ranks 
 Group n Mean Rank Sum of Ranks 
KPCS Score Foster Mothers with Training 9 9.44 85.00 
 Foster Mothers without Training 14 13.65 191.00 
 Total 23     
 
Table 16 
KPCS Scores for Foster Mothers With vs. Without Training (Statistics). 
Test Statisticsa 
 KPCS Score 
Mann-Whitney U 40.00 
Wilcoxon W 85.00 
Z -1.46 
Asymp. Sig. (2-tailed) 0.14 
Exact Sig. [2*(1-tailed Sig.)] 0.16b 
a. Grouping Variable: FM_group 






Given the rising number of infants being born who were prenatally exposed to 
opioids (Ko et al., 2016), gaining a better understanding of this at-risk population and 
their caregivers is essential to providing family-centered care that facilitates resiliency 
and optimal child outcomes. This study sought to identify potential demographic risk and 
protective factors for biological mothers and foster mothers caring for infants who were 
exposed to opioids in utero. It also sought to determine whether prenatal treatment 
programs for biological mothers who used or were treated with opioids during pregnancy, 
and specialized training for foster mothers, would be associated with changes in PSE. 
Results from the current study discovered a significant difference in the 
demographic representation between the biological mother and foster mother samples. 
On average, biological mothers were younger, more likely to be single mothers, and 
reported lower levels of education and household income. Results did not find that PSE 
was higher for biological mothers who participated in treatment programs during their 
current pregnancy compared to biological mothers who participated in treatment 
programs during a past pregnancy. It also did not find that PSE was higher for foster 
mothers who received more than five hours of specialized training relating to prenatal 
drug exposure compared to foster mothers who did not receive specialized training in the 
previous 12 months. Overall, both samples of biological mothers and foster mothers 
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reported relatively high PSE per their responses on the KPCS, regardless of the type of 
treatment program accessed or the hours of specialized training received.  
The significant differences in demographic characteristics discovered between the 
samples of biological mothers and foster mothers adds to the existing literature by 
providing additional insight into demographic risk and protective factors in families 
caring for this population of infants. The finding that biological mothers were younger, 
more likely to be single mothers, and reported lower levels of education and income than 
foster mothers is consistent with previous research studying maternal substance use 
(Haabrekke, Siqveland, Smith, Wentzel-Larsen, & Walhovd, 2015). As previous research 
has also shown, these characteristics are linked to environmental risk factors that may be 
associated with poor developmental outcomes, from physical and mental health to 
cognitive development and language processing skills (Bradley & Corwyn, 2002; 
Fernald, Marchman, & Weisleder, 2013).  
Along with these risk factors, however, protective factors were also identified, 
which can help facilitate family resilience (Benzies & Mychasiuk, 2009) in this 
population. Per Benzies and Mychasiuk (2009), family resilience is the ability of a family 
to use protective factors to cope with adversity. While risk factors increase the likelihood 
of poor outcomes, protective factors act as buffers to adversity and can mitigate negative 
outcomes (Benzies & Mychasiuk, 2009). Within both samples of mothers, higher PSE 
scores might indicate more positive parenting practices that can alleviate potential effects 
of the risk factors mentioned previously (Serbin & Karp, 2004). For foster mothers, more 
adequate household income and better social support can also be a protective factor for 
development (Benzies & Mychasiuk, 2009). Finally, in both samples, mothers were 
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actively engaged in healthcare programs targeting their health as well as the health of 
their child, which presents another protective factor as the use of available healthcare 
services can increase family resiliency (Simon, Murphy, & Smith, 2005). 
The current study is the first to the researchers’ knowledge to examine 
associations between PSE and treatment programs accessed by biological mothers or 
specialized training accessed by foster mothers caring for infants who were prenatally 
exposed to opioids. While a significant association between PSE and participation in 
treatment programs or training was not found, this should not be taken to indicate that 
these interventions are ineffective at influencing PSE in this population. The lack of an 
association, instead, serves to illustrates the multifaceted, dynamic nature of self-efficacy, 
which can be influenced by many internal and external variables (Bandura, 2012), and 
sheds light on how PSE is self-reported among this population of women. 
 Bandura (1982) notes that discrepancies in self-efficacy can occur due to deficient 
self-knowledge, misjudgment of task requirements, and new experiences that can lead to 
a reassessment of one’s self-efficacy, among other factors. Self-efficacy can also differ 
between individuals based on the activity domain itself, as well as specific aspects of the 
given activity (Bandura, 2012). In the current study, nearly a quarter of biological 
mothers in the sample were first-time mothers who might have reported higher PSE due 
to lacking previous personal or vicarious experiences that would enable them to rate their 
own parenting performance accurately. Alternatively, mothers with one or more previous 
children, which included the majority of the foster mothers in the sample, might report 
higher PSE due to already possessing that experiential knowledge. 
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Previous studies have also examined ways in which a parent’s perception of their 
child’s behavior has the potential to influence PSE (Pierce et al., 2010). In a longitudinal 
study of 1,836 mothers, Pierce et al. (2010) found that despite the increased adoption of 
hostile-reactive parenting (HRP) in toddlerhood, there was little change in PSE. The 
authors suggest that although performance is tied to self-efficacy, PSE might have been 
resistant to increasing HRP as mothers attributed negative outcomes to external factors, 
such as difficult child temperament, rather than parenting performance (Pierce et al., 
2010). Given the myriad of symptoms associated with prenatal substance exposure 
(Kocherlakota, 2014), it is possible that mothers in the current study rated their PSE more 
highly because they attributed challenges in care to the infant’s symptoms or behaviors, 
and not their skills as mothers. 
In addition to consideration of these factors, these findings contribute to the 
current PSE literature, which presents inconsistent findings related to of PSE among 
caregivers of medically complex infants and children. For example, in a study of mothers 
of children with autism spectrum disorder (ASD), mothers reported significantly lower 
self-efficacy about parenting their child with ASD than about their typically developing 
child (Meirsschaut et al., 2010). In another study by Porter and Hsu (2003), self-efficacy 
was significantly reduced in mothers of infants who were prone to distress and difficult to 
soothe, which can often be true of infants with a history of prenatal substance exposure 
(Boukydis & Lester, 2008). However, another study found no significant difference in 
PSE between parents of very preterm infants compared to parents of preterm and term 
infants (Pennell, Whittingham, Boyd, Sanders, & Colditz, 2012). Additionally, in a 
longitudinal study of 25 mothers of children with Down syndrome, researchers found that 
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while maternal satisfaction with parenting increased as children grew older, levels of PSE 
did not change and were similar to mothers of typically developing children (Gilmore & 
Cuskelly, 2012). These studies examined different populations of infants and children, of 
course, but it could be assumed that similarities exist in the additional demands and 
stressors placed on parents of these children when compared to parents of typically 
developing children. 
The difference in level of satisfaction with support received from friends between 
biological mothers and foster mothers is also important to note. Previous research has 
suggested that social support can act as a predictor of higher PSE. Teti and Gelfand 
(1991) found that PSE correlated with social-marital supports, while Kersh et al. (2006) 
discovered that while marital quality predicted PSE for mothers, external social support 
predicted PSE for fathers. In addition to being associated with higher self-efficacy, better 
social support may also predict improved mental well-being in first-time mothers (Ginja, 
Coad, Bailey, Kendall, & Goodenough, 2018). In the current study, however, the 
differences in social satisfaction did not influence PSE. 
In addition, about half of all participating mothers indicated that being a mother is 
very stressful some or most of the time per their response to item 22 in the KPCS, 
including 70% of biological mothers and 30% of foster mothers. However, the perceived 
stress related to being a mother was not associated with changes in PSE. This is in 
contrast to previous general parenting research, which has found that increased PSE may 
be related to decreased stress and that higher levels of PSE may mediate adverse effects 
of parenting stress in certain populations, including parents of premature children and 
children with ASD (Kwok & Wong, 2000; Weiss et al., 2013; Woods, 2011). Despite the 
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lack of an association between these variables in the current study, it is worth noting the 
difference in perceived stress between the two samples, with more biological mothers in 
the sample reporting that being a mother is very stressful compared to foster mothers. 
Limitations 
There are several limitations to consider when interpreting the results of this 
study. First, the study had a small sample size of participating biological mothers and 
foster mothers, and it did not include a control group of mothers caring for infants who 
were not prenatally exposed to opioids. The study also relied upon self-report, in which 
parenting constructs may be particularly vulnerable to distortion, and measurement error 
and conscious bias may occur more often compared to records or behavioral observation 
measures (Morsbach & Prinz, 2006). Further, several eligible mothers declined to take 
the survey, potentially indicating that mothers who chose to participate were more 
confident in their parenting skills. It is also possible that some mothers who used 
substances during their pregnancy declined to take the survey due to fear of losing 
custody of their child, fear of punishment by treatment providers and social services, and 
stigmatization around substance use (Bush, 2005; Kahn et al., 2017). Finally, all 
participants lived within or near the Louisville metropolitan area; therefore, responses are 
representative only of a single geographic region with relatively greater access to 
programs when compared to rural communities. 
Clinical Implications 
 This study presents potential demographic risk and protective factors that should 
be taken into consideration by healthcare providers when developing intervention plans 
for children who have a history of prenatal substance exposure. Further, given the 
tendency of biological mothers and foster mothers to report high PSE in the current 
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study, regardless of treatment programs or training accessed, alternative approaches to 
parental education and counseling may be beneficial when providing care to children 
with a history of prenatal substance exposure. For example, mothers could benefit from 
additional guidance or training to accurately self-evaluate skills needed for effective 
carryover of a home exercise program. Education that integrates multiple channels for 
increasing self-efficacy, as proposed by Bandura (1982), might be beneficial. In addition 
to asking mothers to practice a skill (enactive mastery), mothers could benefit from 
observing and analyzing models of the skills (vicarious experience), receiving verbal 
feedback from the therapist (verbal/social persuasion), and identifying ways to reduce 
stress related to parenting (emotional/physiological arousal). Mindfulness-based 
parenting interventions could also be of benefit given the high percentage of mothers in 
this study reporting that being a mother is stressful. Adding mindfulness parenting to 
treatment programs for mothers using substances has been proven effective at reducing 
stress within this at-risk population (Short et al., 2017). Strategies such as mindfulness 
training might also help caregivers increase self-awareness and reflect more accurately on 
complex situations (Benn, Akiva, Arel, & Roeser, 2012). 
Future Directions 
Future research can continue to contribute to an informed understanding of this 
growing population of infants and children, and their caregivers. It can clarify the specific 
support needs to increase resiliency, optimize early experiences, and improve the child-
rearing environment, thereby maximizing long-term developmental outcomes. The 
current study focused only on mothers, but other family members are increasingly 
involved in the care of these infants and children, including fathers, grandparents, aunts, 
and uncles. Future research could include the unique perspectives of this diverse group of 
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caregivers. A research study based on focus group interaction with caregivers is an 
alternate model that could provide rich qualitative data. As the current study examined 
associations with PSE at one point in time, additional research might examine levels of 
PSE before and after an intervention, such as a treatment program geared toward mothers 
using substances or a specialized training program for foster parents. Future studies might 
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